HUBSPOT INC

HUBS

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Eventide Asset Management

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Eventide Asset ManagementNEWFeb 13, 2026

Shares: 89,921Value: $36.1M

**Signal Note: Eventide Initiates HUBS Position** This $36.1M position in HubSpot represents a notable conviction bet by a values-focused manager typically concentrated in biotech/healthcare; the initiation suggests confidence in HUBS's software platform utility for life sciences companies managing commercial operations and customer engagement. While not a direct biotech play, the investment may reflect broader confidence in digital infrastructure benefiting the biotech sector, or portfolio diversification within healthcare IT where HUBS competes for enterprise CRM share.

More HUBS Analysis

Insider buy/sell details with names, titles, and amounts
AI-generated context for every signal

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

CPRT1 fund DECK1 fund LITE1 fund NTAP1 fund GPI1 fund IMMX1 fund PI1 fund UNP1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: